S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)
S&P 500   5,088.80 (+0.03%)
DOW   39,131.53 (+0.16%)
QQQ   436.78 (-0.29%)
AAPL   182.52 (-1.00%)
MSFT   410.34 (-0.32%)
META   484.03 (-0.43%)
GOOGL   143.96 (-0.09%)
AMZN   174.99 (+0.23%)
TSLA   191.97 (-2.76%)
NVDA   788.17 (+0.36%)
NIO   5.40 (-7.69%)
AMD   176.52 (-2.94%)
BABA   75.96 (-0.22%)
T   16.80 (+1.27%)
F   12.15 (+0.25%)
MU   86.00 (+0.10%)
CGC   3.36 (-0.30%)
GE   153.33 (+1.09%)
DIS   107.74 (+0.09%)
AMC   4.43 (+0.23%)
PFE   27.76 (+0.76%)
PYPL   59.16 (+1.39%)
XOM   103.84 (-0.88%)

Windtree Therapeutics (WINT) Earnings Date, Estimates & Call Transcripts

$0.32
0.00 (0.00%)
(As of 02/23/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

WINT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

WINT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Windtree Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($4.34) EPS
Next Year EPS Consensus Estimate: ($1.39) EPS

WINT Earnings Date and Information

Windtree Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 1st, 2024 based off prior year's report dates.

Windtree Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/1/2024
Estimated)
------- 
11/9/2023Q3 2023-($0.86)($0.86)($0.86)--
8/7/2023Q2 2023-($1.64)($1.64)($1.64)--
5/15/2023Q1 2023-($4.76)($4.76)($4.76)--
4/3/2023Q4 2022($10.50)($13.01)($2.51)($13.01)--
11/14/2022Q3 2022($30.00)($13.00)+$17.00($0.13)--
8/11/2022Q2 2022($5.50)($9.50)($4.00)$0.21--
5/5/2022Q1 2022($15.50)($14.50)+$1.00($0.29)--
3/31/2022Q4 2021($16.50)($23.00)($6.50)($0.46)--
11/10/2021Q3 2021($14.50)($15.50)($1.00)($0.31)--
8/5/2021Q2 2021($24.50)($71.00)($46.50)($1.42)--
5/13/2021Q1 2021($15.00)($25.50)($10.50)($0.51)--
3/28/2021Q4 2020($22.50)($21.50)+$1.00($0.44)--












Windtree Therapeutics Earnings - Frequently Asked Questions

When is Windtree Therapeutics's earnings date?

Windtree Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 1st, 2024 based off last year's report dates. Learn more on WINT's earnings history.

How much profit does Windtree Therapeutics generate each year?

Windtree Therapeutics (NASDAQ:WINT) has a recorded net income of -$39.21 million. WINT has generated -$20.27 earnings per share over the last four quarters.

What is Windtree Therapeutics's EPS forecast for next year?

Windtree Therapeutics's earnings are expected to grow from ($4.34) per share to ($1.39) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:WINT) was last updated on 2/23/2024 by MarketBeat.com Staff